A Hyderabad-based nonprofit has opened a free assessment and awareness camp for people with autism, underscoring both a demand for accessible screening and rising public interest in gut-focused therapies. Resplice Autism Research Institute is hosting the camp at its Manikonda facility from October 29 to November 15, between 10 a.m. and 6 p.m. The institute says the drive is meant to help families identify needs early and learn about available support.
What the camp offers - No-cost autism assessments during stated hours at the Manikonda center - Awareness sessions for families and caregivers focused on early identification, intervention pathways, and support - Referrals to services where appropriate, according to the institute’s stated mission
About the institute and its therapy claims Resplice describes itself as a research-focused center working to address biological and environmental factors associated with autism. It also says it is India’s first center to provide fecal microbiota transplantation (FMT) for autistic children. FMT involves transferring processed stool from a healthy donor to a recipient to help restore gut microbial balance. While FMT is an accepted approach for some gastrointestinal infections in certain settings, its use in autism remains investigational.
Early-stage studies have explored links between the microbiome and autism-related gastrointestinal (GI) symptoms, with some small trials reporting improvements in GI function and behavioral measures following microbiota-focused interventions. However, results are not definitive, sample sizes have been limited, and many studies are open-label, making firm conclusions premature. Major health authorities and researchers caution that FMT for autism should be pursued only under rigorous clinical protocols with careful donor screening, long-term follow-up, and transparent reporting of risks and benefits.
What families should ask before considering experimental therapies - Evidence base: What peer-reviewed studies support the intervention for autism? What outcomes were measured, and over what time frame? - Safety: How are donors screened? What are known risks, including infection transmission, immune reactions, or other adverse events? - Oversight: Is the procedure part of a registered clinical study with ethics approval and clear consent processes? - Alternatives: How will the proposed therapy integrate with established supports such as speech and language therapy, occupational therapy, behavioral interventions, and GI care? - Costs and follow-up: What are the short- and long-term costs, monitoring needs, and contingency plans if side effects occur?
Autism care landscape: access and awareness Families across Telangana—and India more broadly—often navigate a patchwork of diagnostic and support options that vary by location and cost. A camp offering free assessments can reduce barriers for families who suspect developmental differences but have yet to receive a formal evaluation. Early identification is associated with better outcomes because it can help children access interventions during key developmental windows.
Evidence-based supports typically include speech and language therapy, occupational therapy, behavioral and educational interventions, and treatment of co-occurring conditions such as anxiety, sleep problems, or GI issues. While research into biological and environmental factors is important, clinicians emphasize that experimental treatments should complement, not replace, established care tailored to individual needs.
Microbiome science and autism: what we know - Many autistic individuals experience GI symptoms, and studies have found differences in gut microbiota profiles compared with non-autistic peers. The direction of causality is not fully understood. - Interventions aimed at the microbiome range from dietary adjustments and probiotics to more intensive approaches like FMT. Safety, efficacy, and durability of effects vary and remain under active investigation. - Regulators in several countries have issued safety notices around FMT due to documented risks when donor screening and clinical protocols are inadequate. For autism specifically, FMT is not a standard-of-care treatment.
The personal drive behind the initiative Resplice’s leadership has described a mission grounded in addressing root biological and environmental contributors to autism, informed by lived experience as parents. The camp is positioned as a community-facing effort to broaden access to assessments, share information, and connect families with resources.
Navigating choices: practical steps for families - Start with a comprehensive evaluation by qualified clinicians experienced in developmental assessments. - Discuss any experimental options with a pediatrician or specialist who can weigh risks, benefits, and the strength of current evidence. - Prioritize continuity of care: ensure that any new intervention aligns with existing therapies and educational plans. - Keep records of interventions and outcomes to support data-informed decisions over time.
The bottom line Hyderabad’s free assessment camp offers immediate, practical value for families seeking screening and guidance. At the same time, the institute’s spotlight on FMT reflects a wider curiosity about microbiome-based approaches in autism—an area where science is evolving but not settled. For families, the dual message is clear: take advantage of accessible assessments and proven supports, and approach experimental therapies with informed caution and appropriate clinical oversight.